CD39, Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CD39, Mouse antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD39, Mouse |
| Clone | REA870 |
| Host Species | Recombinant Human |
| Reactive Species | mouse |
| Isotype | IgG1 |
| Format | biotin conjugate |
| Size | 30 µg in 200 µL |
| Concentration | 1:50 |
| Applications | Flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CD39 Antibody, anti-mouse, Biotin, REAfinity™. Clone REA870 recognizes the mouse ecto-nucleoside triphosphate diphosphohydrolase enzyme CD39, also known as NTPDase or Entpd1. CD39 is primarily found on activated lymphoid cells, B cells, Langerhans cells, and most monocytes. It catalyses the hydrolysis of γ- and β-phosphate residues of triphospho- and diphosphonucleosides to the monophosphonucleoside derivative. | Additional information: Clone REA870 displays negligible binding to Fc receptors. |
| Immunogen | n/a |
| Other Names | NTPDase 1, Entpd1 |
| Gene, Accession # | Gene ID: 12495 |
| Catalog # | 130-114-355 |
| Price | $66 |
| Order / More Info | CD39, Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Maliszewski, C. R. et al. (1994) The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol 153 (8): 3574-3583. | Robson, S. C. et al. (2006) The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal. 2 (2): 409-430. | Yegutkin, G. G. et al. (2008) Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim. Biophys. Acta 1783 (5): 673-694. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies